| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 472-475, Copyright © 1993 by Endocrine Society
ARTICLES |
KE Elkind-Hirsch, LD Sherman and R Malinak
Department of Medicine, Methodist Hospital, Houston, Texas 77030.
In this study, we report the effects of cyclic hormone replacement therapy on carbohydrate metabolism in six women with premature ovarian failure. Using tolbutamide-modified iv glucose tolerance tests patients were evaluated during three different intervals of their second treatment cycle: no hormone replacement, estradiol-only (E2-only) replacement, and E2-plus-medroxyprogesterone acetate (MPA) replacement. Insulin sensitivity and glucose effectiveness were derived using insulin and glucose levels obtained from tolbutamide-modified iv glucose tolerance tests and analyzed with the minimal model computer program. The mean insulin sensitivity (x 10(-4)/min/microU.ml) significantly decreased from 4.0 +/- 0.8 during no hormone replacement and 3.8 +/- 0.8 during E2-only replacement to 2.6 +/- 0.5 (x 10(- 4)/min/microU/ml) during E2-plus-MPA replacement (P < 0.005). Glucose effectiveness did not change as a function of the phase of hormone replacement therapy. These findings indicate a significant decrease in sensitivity to insulin associated with MPA treatment but no observable change in insulin sensitivity during the E2-only phase of cyclic steroid replacement therapy in young women. Our results support the hypothesis that impairment of insulin-mediated glucose uptake during the luteal phase of the menstrual cycle is due to increased progesterone secretion.
This article has been cited by other articles:
![]() |
T. Bagis, A. Gokcel, H. B. Zeyneloglu, E. Tarim, E. B. Kilicdag, and B. Haydardedeoglu The Effects of Short-Term Medroxyprogesterone Acetate and Micronized Progesterone on Glucose Metabolism and Lipid Profiles in Patients with Polycystic Ovary Syndrome: A Prospective Randomized Study J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4536 - 4540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cagnacci, A. M. Paoletti, A. Zanni, S. Arangino, G. Ibba, M. Orru, G. B. Melis, and A. Volpe Raloxifene Does Not Modify Insulin Sensitivity and Glucose Metabolism in Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4117 - 4121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Campbell and M. A. Febbraio Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1139 - E1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Saad, B. S. Keenan, K. Danadian, V. D. Lewy, and S. A. Arslanian Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty? J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4881 - 4886. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Campbell and M. A. Febbraio Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E803 - E808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Friday, C. Dong, and R. U. Fontenot Conjugated Equine Estrogen Improves Glycemic Control and Blood Lipoproteins in Postmenopausal Women with Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 48 - 52. [Abstract] [Full Text] |
||||
![]() |
A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407. [Abstract] [Full Text] |
||||
![]() |
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism Hum. Reprod., April 1, 1999; 14(4): 893 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Braun, G. E. Butterfield, S. B. Dominick, S. Zamudio, R. G. McCullough, P. B. Rock, and L. G. Moore Women at altitude: changes in carbohydrate metabolism at 4,300-m elevation and across the menstrual cycle J Appl Physiol, November 1, 1998; 85(5): 1966 - 1973. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wagner, M. J. Thomas, J. K. Williams, L. Zhang, K. A. Greaves, and W. T. Cefalu Insulin Sensitivity and Cardiovascular Risk Factors in Ovariectomized Monkeys with Estradiol Alone or Combined with Nomegestrol Acetate J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 896 - 901. [Abstract] [Full Text] |
||||
![]() |
A. Dunaif Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis Endocr. Rev., December 1, 1997; 18(6): 774 - 800. [Abstract] [Full Text] |
||||
![]() |
A. Cagnacci, E. Mallus, F. Tuveri, R. Cirillo, A. M. Setteneri, and G. B. Melis Effect of Tibolone on Glucose and Lipid Metabolism in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 251 - 253. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |